YAKC Yak Communications

OTC Growth Stock Watch Issues Aggressive Buy Recommendation on Yak Communications NEEDHAM, Mass., May 21 /PRNewswire/ -- OTC Growth Stock Watch, an independent newsletter published by OTC Research Corp., announced today that it has issued an 'Aggressive Buy' Recommendation on Yak Communications in its May 15, 2004 issue. The buy recommendation issued on Yak Communications includes a profile of the Company's comprehensive business strategies, proprietary technologies and impressive growth prospects. Geoffrey Eiten, publisher of OTC Growth Stock Watch said, "As a telecomm re-seller, Yak is taking advantage of growing trends in telecommunications. As the Company continues to capitalize on increasing demands for high quality international telecommunication services resulting from the increase in immigrant populations, the globalization of the world economies, the worldwide trend towards telecommunication deregulation and the growth of international voice and data traffic, we expect to see significant sequential growth from the Company over the near and long term." About OTC Growth Stock Watch OTC Growth Stock Watch has been published since 1979 and is one of the most respected and referred-to guides to discovering high-performance NASDAQ(R) and AMEX(R) Stocks. Geared toward aggressive, growth-oriented investors, OTC Growth Stock Watch reports on companies with a market capitalization under $100 million dollars, which meet a set of Publisher and Chief Analyst Geoffrey Eiten's rigid performance criteria. Since very few public corporations meet OTC Growth Stock Watch's rigid performance criteria, the GSW staff investigates hundreds of companies each month. After thorough research and analysis, OTC Growth Stock Watch is edited, printed, and mailed first-class, emailed or faxed to paid subscribers every month, guaranteeing current information for use right away. Please visit http://www.otcgsw.com/ for detailed subscription information. Contact: Geoffrey Eiten, Publisher, 781-444-6100 x613 or with any questions. Disclaimer: OTC Growth Stock Watch, published by OTC Research Corp., endeavors to supply its subscribers with sound opinions and advice based on its analysis of publicly available information from sources believed to be reliable, but makes no representation as to its accuracy or completeness. Opinions and advice of OTC Growth Stock Watch are not based upon individual needs or investment objectives of subscribers nor are they an offer to buy or sell securities. Since many company issues featured may carry above average risk, OTC Growth Stock Watch recommendations should be bought only by investors financially able to purchase speculative stocks. OTC Growth Stock Watch, its affiliates and subsidiaries and/or their officers and employees may from time to time acquire, hold or sell a position in the securities mentioned in its newsletters. Upon request, the Company will be pleased to furnish specific information in this regard. Additional information on any securities discussed is available upon request. DATASOURCE: OTC Research Corp. CONTACT: Geoffrey Eiten, Publisher of OTC Research Corp., +1-781-444- 6100 ext. 613,

Copyright